Armata Pharmaceuticals Strengthens Intellectual Property Portfolio with New Patent Allowances in Europe and Canada

Link to Full Article Patent allowances cover various aspects of the Company’s phage program and lead product candidate, AP-SA01 Company to host bacteriophage Key Opinion Leader meeting and live webcast on Wednesday, June 26 MARINA DEL REY, Calif., June 3, 2019 /PRNewswire/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP), a clinical-stage biotechnology company focused on precisely targeted bacteriophage […]

AVITA Medical Announces Presentation at ABA Meeting Highlighting Results of Study Using RECELL® System to Treat Third-Degree Burns in Pediatric Patients

Professor Fiona Wood, co-inventor of the RECELL System, described her experience treating more than 3,500 patients using RECELL and resulting benefits including reduced time to healing and decreased length of hospitalization The publication of the RECELL System pivotal trial in the treatment of second-degree burns was selected as a top journal publication for 2018 Link […]